Wilmer Cutler Pickering Hale and Dorr advised Cue Biopharma, and Paul Hastings advised the underwriters on the offering. Cue Biopharma (Nasdaq: CUE), a clinical-stage biopharmaceutical company,...
Cue Biopharma’s $20 Million Common Stock Offering
Tellurian’s $50 Million Senior Notes Offering
Davis Polk advised the joint book-running managers in the offering. Tellurian Inc. executed its offering of $50 million principal amount of 8.250% senior notes due 2028. The net...